☆ 4.6 Letter

APOL1, α-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia

HAEMATOLOGICA (2017)

期刊

HAEMATOLOGICA

卷 102, 期 1, 页码 E1-E6

出版社

FERRATA STORTI FOUNDATION

DOI: 10.3324/haematol.2016.154153

关键词

-

类别

Hematology

资金

National Institutes of Health [K23HL125984, R01HL078536, R01HL111656, R01HL127342, K24-DK092290]

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Hematology

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea

Pierre Allard, Nareen Alhaj, Stephan Lobitz, Holger Cario, Andreas Jarisch, Regine Grosse, Lena Oevermann, Dani Hakimeh, Laura Tagliaferri, Elisabeth Kohne, Annette Kopp-Schneider, Andreas E. Kulozik, Joachim B. Kunz

Summary: This study analyzed the modifying effect of HbF-related genetic polymorphisms in 417 patients with homozygous SCD over 2 years old who received hydroxyurea, finding that certain polymorphisms were associated with increased HbF levels but did not reduce the frequency of vaso-occlusive events. Patients carrying the γ-globin promoter polymorphism may have higher hemoglobin levels and more frequent painful crises.

HAEMATOLOGICA (2022)

添加到收藏夹

Article Urology & Nephrology

APOL1 Kidney Risk Variants and Proteomics

Teresa K. Chen, Aditya L. Surapaneni, Dan E. Arking, Christie M. Ballantyne, Eric Boerwinkle, Jingsha Chen, Josef Coresh, Anna Koettgen, Katalin Susztak, Adrienne Tin, Bing Yu, Morgan E. Grams

Summary: The APOL1 risk variants are associated with kidney disease among Black adults, and this study explores their relationship with the circulating proteome, finding that APOL1 risk variants are strongly associated with lower levels of various proteins.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

添加到收藏夹

Article Urology & Nephrology

APOL1 Renal Risk Variants and Sickle Cell Trait Associations With Reduced Kidney Function in a Large Congolese Population-Based Study

Mannix Imani Masimango, Michel Jadoul, Elizabeth A. Binns-Roemer, Victor A. David, Ernest Kiswaya Sumaili, Cheryl A. Winkler, Sophie Limou

Summary: APOL1, GSTM1 risk variants, and sickle cell trait (SCT) are associated with chronic kidney disease (CKD) among African Americans (AAs), but there is scarce evidence in sub-Saharan Africa (SSA) populations. Our study highlights the impact of APOL1 and SCT variants on poorer renal outcomes in the Democratic Republic of Congo (DRC) and advocates for further genetic studies in SSA.

KIDNEY INTERNATIONAL REPORTS (2022)

添加到收藏夹

Article Immunology

APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis

Junnan Wu, Ziyuan Ma, Archana Raman, Pazit Beckerman, Poonam Dhillon, Dhanunjay Mukhi, Matthew Palmer, Hua Chang Chen, Cassiane Robinson Cohen, Thomas Dunn, John Reilly, Nuala Meyer, Michael Shahaty, Zoltan Arany, Gyorgy Hasko, Krzysztof Laudanski, Adriana Hung, Katalin Susztak

Summary: The incidence and severity of sepsis is higher among individuals of African versus European ancestry, with genetic risk variants in APOL1 associated with increased sepsis incidence and severity. APOL1 levels correlated with sepsis and COVID-19 severity, and targeting the inflammasome and STING pathways may help reduce APOL1-associated endothelial changes in sepsis.

IMMUNITY (2021)

添加到收藏夹

Article Medicine, General & Internal

HIV Viremia Is Associated With APOL1 Variants and Reduced JC-Viruria

Etty Kruzel-Davila, Barbara Mensah Sankofi, Ernestine Kubi Amos-Abanyie, Anita Ghansah, Alexander Nyarko, Seth Agyemang, Gordon A. Awandare, Moran Szwarcwort-Cohen, Anat Reiner-Benaim, Basem Hijazi, Ifeoma Ulasi, Yemi Raheem Raji, Vincent Boima, Charlotte Osafo, Victoria May Adabayeri, Michael Matekole, Timothy O. Olanrewaju, Samuel Ajayi, Manmak Mamven, Sampson Antwi, Adebowale D. Ademola, Jacob Plange-Rhule, Fatiu Arogundade, Priscilla Abena Akyaw, Cheryl A. Winkler, Babatunde L. Salako, Akinlolu Ojo, Karl Skorecki, Dwomoa Adu

Summary: Variants in the APOL1 gene are associated with an increased risk of non-diabetic chronic kidney disease and HIV associated nephropathy. Carrying two APOL1 risk alleles increases the risk of these kidney diseases, as well as HIV infectivity.

FRONTIERS IN MEDICINE (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies

Megane Brusson, Anne Chalumeau, Pierre Martinucci, Oriana Romano, Tristan Felix, Valentina Poletti, Samantha Scaramuzza, Sophie Ramadier, Cecile Masson, Giuliana Ferrari, Fulvio Mavilio, Marina Cavazzana, Mario Amendola, Annarita Miccio

Summary: Sickle cell disease (SCD) is caused by a mutation in the O-globin gene, resulting in the production of toxic sickle hemoglobin (HbS). Researchers have developed a bifunctional lentiviral vector that expresses anti-sickling O-globin (OAS3) and a specific artificial microRNA (amiRNA) to downregulate OS-globin expression. This treatment effectively reduces HbS levels and corrects the sickling phenotype in SCD hematopoietic stem and progenitor cells (HSPCs), outperforming other gene addition and gene silencing strategies. The safety of this therapeutic approach has been confirmed.

MOLECULAR THERAPY-NUCLEIC ACIDS (2023)

添加到收藏夹

Article Hematology

APOL1 Genetic Variants Are Associated With Increased Risk of Coronary Atherosclerotic Plaque Rupture in the Black Population

Anne Cornelissen, Daniela T. Fuller, Raquel Fernandez, Xiaoqing Zhao, Robert Kutys, Elizabeth Binns-Roemer, Marco Delsante, Atsushi Sakamoto, Ka Hyun Paek, Yu Sato, Rika Kawakami, Masayuki Mori, Kenji Kawai, Teruhiko Yoshida, Khun Zaw Latt, Clint L. Miller, Paul S. de Vries, Frank D. Kolodgie, Renu Virmani, Myung Kyun Shin, Maarten Hoek, Jurgen Heymann, Jeffrey B. Kopp, Avi Z. Rosenberg, Harry R. Davis, Liang Guo, Aloke V. Finn

Summary: The study found that APOL1 risk alleles are associated with coronary artery disease, with carriers being more prone to thrombotic events. Individuals with 2 APOL1 risk alleles have larger necrotic cores in plaques, suggesting a role of APOL1 in determining plaque stability.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

添加到收藏夹

Article Urology & Nephrology

APOL1 Risk Variants Associated with Serum Albumin in a Population-Based Cohort Study

Ninad S. Chaudhary, Hemant K. Tiwari, Bertha A. Hidalgo, Nita A. Limdi, Richard J. Reynolds, Mary Cushman, Neil A. Zakai, Leslie Lange, Suzanne E. Judd, Cheryl A. Winkler, Jeffrey B. Kopp, Orlando M. Gutierrez, Marguerite R. Irvin

Summary: APOL1 high-risk variants are associated with reduced serum albumin levels, but serum albumin does not mediate the association between APOL1 and incident end-stage kidney disease.

AMERICAN JOURNAL OF NEPHROLOGY (2022)

添加到收藏夹

Article Urology & Nephrology

APOL1 Risk Variants and Acute Kidney Injury in Black Americans with COVID-19

Christopher P. Larsen, Terrance J. Wickman, Juarez R. Braga, Luis A. Matute-Trochez, Anna E. Hasty, Lyndsey R. Buckner, John M. Arthur, Randy S. Haun, Juan Carlos Q. Velez

Summary: APOL1 high-risk alleles are associated with greater odds of AKI in Black American patients with COVID-19.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

添加到收藏夹

Review Chemistry, Medicinal

Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent f3-Thalassemia (NTDT): Design, Development and Potential Place in Therapy

Khaled M. Musallam, Ali T. Taher, Antonis Kattamis, Kevin H. M. Kuo, Sujit Sheth, Maria Domenica Cappellini

Summary: Over the past years, evidence has accumulated on the harmful clinical consequences of untreated anemia in patients with non-transfusion-dependent f3-thalassemia (NTDT). Currently, there are no approved pharmacologic agents for anemia management in NTDT, and available options such as splenectomy, transfusion therapy, and hydroxyurea have their own limitations, especially for long-term use. Luspatercept, an erythroid maturation agent, was evaluated in a Phase 2 trial and demonstrated a significant benefit in raising hemoglobin level by at least 1 g/dL in adults with NTDT and a baseline hemoglobin level <= 10 g/dL. These findings led to the approval of luspatercept by the European Commission for treating anemia in adults with NTDT, providing the first evidence-based approach for improving anemia in this patient population.

DRUG DESIGN DEVELOPMENT AND THERAPY (2023)

添加到收藏夹

Article Urology & Nephrology

Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV

Rachel K. Y. Hung, Elizabeth Binns-Roemer, John W. Booth, Rachel Hilton, Mark Harber, Beatriz Santana-Suarez, Lucy Campbell, Julie Fox, Andrew Ustianowski, Catherine Cosgrove, James E. Burns, Amanda Clarke, David A. Price, David Chadwick, Denis Onyango, Lisa Hamzah, Kate Bramham, Caroline A. Sabin, Cheryl A. Winkler, Frank A. Post

Summary: APOL1 high-risk genotypes are strongly associated with kidney disease in people of African ancestry with HIV and account for approximately half of ESKD cases in this cohort.

KIDNEY INTERNATIONAL REPORTS (2022)

添加到收藏夹

Article Urology & Nephrology

APOL1 Renal Risk Variants and Kidney Function in HIV-1-Infected People From Sub-Saharan Africa

Nongodo Firmin Kabore, Amandine Cournil, Armel Poda, Laura Ciaffi, Elizabeth Binns-Roemer, Victor David, Sabrina Eymard-Duvernay, Jacques Zoungrana, Aoua Semde, Adrien B. Sawadogo, Sinata Koulla-Shiro, Charles Kouanfack, Ndeye Fatou Ngom-Gueye, Nicolas Meda, Cheryl Winkler, Sophie Limou

Summary: This study aimed to investigate the performance of APOL1 G1 and G2 alleles in PLHIV in West Africa. The results showed that the high-risk alleles of APOL1 gene were more common in PLHIV in West African countries than in Cameroon. Additionally, the study found that virological status may modulate the impact of APOL1 on kidney function.

KIDNEY INTERNATIONAL REPORTS (2022)

添加到收藏夹

Article Hematology

miRNA profile and disease severity in patients with sickle cell anemia

Thais Priscila Biassi, Elvira Maria Guerra-Shinohara, Patricia Natalia Silva Moretti, Valeria de Freitas Dutra, Ana Carolina Cabanas-Pedro, Grazielle Mecabo, Gisele Wally Braga Colleoni, Maria Stella Figueiredo

Summary: Screening of circulating serum microRNAs in sickle cell anemia patients identified 17 miRNAs associated with disease severity, among which miR15b, miR502, miR510, miR544, and miR629 were further validated. The study suggests that low levels of miR510 and miR629 expression are linked to greater severity in sickle cell anemia, demonstrating their potential as biomarkers for disease severity. Further research is needed to understand the mechanisms of these miRNAs and their associated proteins.

ANNALS OF HEMATOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis

Mengyuan Ge, Judith Molina, G. Michelle Ducasa, Shamroop K. Mallela, Javier Varona Santos, Alla Mitrofanova, Jin-Ju Kim, Xiaochen Liu, Alexis Sloan, Armando J. Mendez, Santanu Banerjee, Shaoyi Liu, Hazel H. Szeto, Myung K. Shin, Maarten Hoek, Jeffrey B. Kopp, Flavia Fontanesi, Sandra Merscher, Alessia Fornoni

Summary: The study reveals that the expression of the APOL1 risk variant G1 exacerbates proteinuria and kidney function damage in an FSGS mouse model, leading to lipid accumulation in kidney cortices and impaired renal function. Additionally, expression of APOL1 G1/G2 in human urinary podocytes is associated with increased cellular triglyceride content and mitochondrial dysfunction.

HUMAN MOLECULAR GENETICS (2021)

添加到收藏夹

Review Medicine, General & Internal

Systematic Literature Review Shows Gaps in Data on Global Prevalence and Birth Prevalence of Sickle Cell Disease and Sickle Cell Trait: Call for Action to Scale Up and Harmonize Data Collection

Raffaella Colombatti, Inga Hegemann, Morten Medici, Camilla Birkegard

Summary: Sickle cell disease is a genetic disorder with a high prevalence in sub-Saharan Africa, the Mediterranean basin, the Middle East, and India. A systematic literature review identified 115 publications on SCD epidemiology, showing highest prevalence in Africa, the Middle East, and India, and lowest in Europe. The study revealed a lack of systematic knowledge and the need for uniform data collection on SCD prevalence and mortality.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Letter Hematology

COVID-19 infection in patients with sickle cell disease

Faiz A. Hussain, Franklin U. Njoku, Santosh L. Saraf, Robert E. Molokie, Victor R. Gordeuk, Jin Han

BRITISH JOURNAL OF HAEMATOLOGY (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso-occlusive Pain Crises in Patients with Sickle Cell Disease

Jin Han, Santosh L. Saraf, Victor R. Gordeuk

PHARMACOTHERAPY (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Systematic Review of Voxelotor: A First-in-Class Sickle Hemoglobin Polymerization Inhibitor for Management of Sickle Cell Disease

Jin Han, Santosh L. Saraf, Victor R. Gordeuk

PHARMACOTHERAPY (2020)

添加到收藏夹

Article Surgery

Evaluation of Extra-axillary Lymph Nodes by Ultrasound in Breast Cancer Patients

Era Parasar, Rahul Khanna, Ashish Verma, Shivi Jain, Seema Khanna

Summary: The study evaluated the extra-axillary lymph nodes in 228 breast cancer patients using Doppler ultrasonogram, finding a higher rate of involvement in T3 and T4 lesions, with internal mammary nodes being most commonly affected. Assessment of extra-axillary lymph nodes is crucial for avoiding understaging and guiding treatment in breast cancer patients.

INDIAN JOURNAL OF SURGERY (2021)

添加到收藏夹

Article Hematology

Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection

Caterina P. Minniti, Ahmar U. Zaidi, Mehdi Nouraie, Deepa Manwani, Gary D. Crouch, Andrew S. Crouch, Michael U. Callaghan, Sarah Carpenter, Charleen Jacobs, Jin Han, Jena Simon, Jeffrey Glassberg, Victor R. Gordeuk, Elizabeth S. Klings

Summary: In patients with SCD and COVID-19, factors associated with mortality include preexisting renal disease, older age, history of pulmonary hypertension, congestive heart failure, as well as higher levels of creatinine, lactate dehydrogenase, and D-dimer.

BLOOD ADVANCES (2021)

添加到收藏夹

Letter Pharmacology & Pharmacy

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Jin Han, Santosh L. Saraf, Michel Gowhari, Faiz Ahmed Hussain, Shivi Jain, Laura Kavoliunaite, Robert E. Molokie, Victor R. Gordeuk

ANNALS OF PHARMACOTHERAPY (2022)

添加到收藏夹

Article Hematology

Biomarkers of clinical severity in treated and untreated sickle cell disease: a comparison by genotypes of a single center cohort and African Americans in the NHANES study

Franklin Njoku, Xu Zhang, Binal N. Shah, Roberto F. Machado, Jin Han, Santosh L. Saraf, Victor R. Gordeuk

Summary: Real-world biomarker assessments in adult SCD patients at the University of Illinois revealed significant differences in markers of haemolysis, inflammation, and organ function between severe and mild genotypes. While untreated mild genotype patients showed biomarkers closer to control ranges, severe genotype patients receiving treatment did not significantly improve, indicating a need for more effective treatments.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Sphingosine Kinase 1 Regulates the Pulmonary Vascular Immune Response

Yang Bai, Angelia D. Lockett, Marta T. Gomes, Robert S. Stearman, Roberto F. Machado

Summary: The aberrant proliferation of pulmonary artery smooth muscle cells caused by over-expression of SPHK1 leads to changes in genes regulating cellular immune response, with elevated levels of IL6, STAT1, and PARP9. These differentially expressed genes are mapped to immune-modulatory signaling networks, including IFNG. Additionally, PARP9 and STAT1 proteins were found to be elevated in primary hPASMCs isolated from PAH patients.

CELL BIOCHEMISTRY AND BIOPHYSICS (2021)

添加到收藏夹

Letter Hematology

Voxelotor and albuminuria in adults with sickle cell anaemia

Jin Han, Robert E. Molokie, Faiz Hussain, Franklin Njoku, Victor R. Gordeuk, Santosh L. Saraf

BRITISH JOURNAL OF HAEMATOLOGY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Changing from mandatory to optional genotyping results in higher acceptance of pharmacist-guided warfarin dosing

Ashwini Zolekar, Kibum Kim, James C. Lee, Jin Han, Julio D. Duarte, William L. Galanter, Larisa H. Cavallari, Edith A. Nutescu

Summary: The study found that genotype testing for warfarin remained high even after transitioning to optional genotyping, with majority of eligible patients still opting for it. Physician acceptance of pharmacist-recommended doses increased after the transition, with shorter turnaround time for genotype results in the optional genotyping group.

PHARMACOGENOMICS (2021)

添加到收藏夹

Article Obstetrics & Gynecology

Correlation of Clinical, Hormonal, Biochemical and Ultrasound Parameters Between Adult and Adolescent Polycystic Ovarian Syndrome Adult and Adolescent PCOS

Shivi Jain, Madhu Jain, R. C. Shukla

Summary: There was no statistically significant difference noted in PCOS between adult and adolescent patients. Elevated LH/FSH ratio and free testosterone levels were observed in both adult and adolescent PCOS patients compared to controls. The majority of PCOS patients exhibited multiple follicles on ultrasound examination.

JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Genotype-Guided vs Clinically-Guided Stable Warfarin Dose Prediction and Stable Dose Establishment In A Predominantly Non-European Ancestry Population

Annesti F. Elmasri, Heejin Hur, Jin Han, James C. Lee

Summary: Genotype-guided warfarin dosing did not improve eventual stable dose discordance or reduce the time to achieve stable dose in this predominantly non-European cohort. Dietary vitamin K intake level did not impact warfarin dose discordance or time to achieve stable warfarin dose. Additional study is needed to identify populations that best benefit from PGx-guided warfarin dosing.

EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT (2021)

添加到收藏夹

Article Physiology

Cortactin loss protects against hemin-induced acute lung injury in sickle cell disease

Nicole M. Jones, Justin R. Sysol, Sunit Singla, Patricia Smith, George E. Sandusky, Huashan Wang, Viswanathan Natarajan, Steven M. Dudek, Roberto F. Machado

Summary: This study investigated the role of the cytoskeletal protein cortactin (CTTN) in hemin-induced acute lung injury (ALI) and acute chest syndrome (ACS). The results showed that cortactin deficiency provided protection against hemin-induced injury in mice and in vitro cell models, suggesting a new potential treatment avenue for this devastating disease.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2022)

添加到收藏夹

Article Hematology

Evaluation of point-of-care International Normalized Ratio in sickle cell disease

Syeda Rahman, Andrew Srisuwananukorn, Robert E. Molokie, Michel Gowhari, Franklin Njoku, Faiz Ahmed Hussain, James Lee, Edith A. Nutescu, Victor R. Gordeuk, Santosh L. Saraf, Jin Han

Summary: The study found that the percentage of in-range POC-INR values in patients with sickle cell disease and non-SCD Black cohort were similar, indicating a high correlation when POC-INR <4.0. Applying a correction factor improved the accuracy of POC-INR values >= 4.0 significantly.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Letter Hematology

Antimicrobial resistance is a risk factor for mortality in adults with sickle cell disease

Andrew Srisuwananukorn, Jin Han, Rasha Raslan, Michel Gowhari, Faiz Hussain, Franklin Njoku, Robert E. Molokie, Victor R. Gordeuk, Santosh L. Saraf

HAEMATOLOGICA (2021)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.